Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial.
about
Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablationElectrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation.Who Needs Catheter Ablation And Which Approach?Elimination Of Triggers Without An Additional Substrate Modification Is Not Sufficient In Patients With Persistent Atrial FibrillationPredictors of Recurrence After Catheter Ablation of Persistent Atrial FibrillationStaged transthoracic approach to persistent atrial fibrillation (TOP-AF): study protocol for a randomized trial.Safety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysisEfficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials.Improving ablation strategies for the treatment of atrial fibrillation.Interventional treatment of atrial fibrillation - contemporary methods and perspectives.Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study.The role of fibroblasts in complex fractionated electrograms during persistent/permanent atrial fibrillation: implications for electrogram-based catheter ablation.Cryoballoon ablation for atrial fibrillation.eNOS3 Genetic Polymorphism Is Related to Post-Ablation Early Recurrence of Atrial Fibrillation.Current issues in atrial fibrillation.Atrial Substrate Modification in Atrial Fibrillation: Targeting GP or CFAE? Evidence from Meta-Analysis of Clinical Trials.Arrhythmia Termination Versus Elimination of Dormant Pulmonary Vein Conduction as a Procedural End Point of Catheter Ablation for Paroxysmal Atrial Fibrillation: A Prospective Randomized TrialAblating persistent atrial fibrillation successfully.Clinical Significance of Additional Ablation of Atrial Premature Beats after Catheter Ablation for Atrial Fibrillation.Mechanisms of Atrial Fibrillation - Reentry, Rotors and RealityMinimizing discordances in automated classification of fractionated electrograms in human persistent atrial fibrillation.Challenging Achievement of Bidirectional Block After Linear Ablation Affects the Rhythm Outcome in Patients With Persistent Atrial Fibrillation.Necessity of Repeat Ablations to Eliminate Atrial Fibrillation.Comparing Safety and Efficacy of Irrigated Radiofrequency Catheter Ablation Versus Combined Cryoballoon and Catheter Ablation for Persistent Atrial Fibrillation.A Thin Left Atrial Antral Wall Around the Pulmonary Vein Reflects Structural Remodeling by Atrial Fibrillation and is Associated with Stroke.Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation.Efficacy of cardiac autonomic denervation for atrial fibrillation: a meta-analysis.Current hot potatoes in atrial fibrillation ablation.Venice Chart international consensus document on atrial fibrillation ablation: 2011 update.Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis.Contemporary approaches to persistent atrial fibrillation.Update on atrial fibrillation catheter ablation technologies and techniques.Catheter ablation of persistent atrial fibrillation.Catheter Ablation of Atrial Fibrillation to Maintain Sinus Rhythm.Unanswered Questions in Complex Fractionated Atrial Electrogram Ablation.New Insights On Ablation Of Persistent Atrial Fibrillation: Evidence From The SARA Trial.The burden of proof: The current state of atrial fibrillation prevention and treatment trials.Adjunctive ablation strategies improve the efficacy of pulmonary vein isolation in non-paroxysmal atrial fibrillation: a systematic review and meta-analysis.What Is the Appropriate Lesion Set for Ablation in Patients with Persistent Atrial Fibrillation?
P2860
Q26864767-80EEEAD3-471C-445D-998D-99609F70D184Q28073160-4E1E3005-7272-4A8E-9EB0-0E1E0A5095F4Q28074710-64B18808-8095-4156-8445-4D94BFCA8FDEQ28084012-80F7B6CD-D73F-4F20-A462-5A93B0B338ABQ30318198-1F75DFED-71FB-493B-94E7-6D62FDC4258AQ33789048-EFA63737-76C0-4E7E-8863-FC5640E653CAQ33941583-F9552700-A8D5-49C8-9587-30CAB19B0F08Q34472307-2C5BA540-3009-411A-B73C-D56C631196A9Q34505587-BF9650AE-77B9-4A80-97BC-D2C497FEB83CQ35059670-7C59F045-39DA-464F-B90B-F7C42EAE5CC6Q35212904-95C0ECE7-09C8-40F6-A179-5D489693CF37Q35773242-7854BDFD-4CAA-48A0-AE9F-7778ECAB2430Q35855849-3A9CC80E-3EAB-42CE-A223-EF974364DD10Q35914686-11028A7C-D8F5-4BF7-8D98-143BD8ED370DQ35971046-85731048-6257-436D-BB73-3A6A47EFBD41Q36072140-63B18D08-BE87-487B-8889-5CD852850D97Q36169327-267721CA-A4A1-46AC-BD46-258C6D84272FQ36170147-07FD7381-EB6C-46A0-901A-769E33163CACQ36283008-E1893297-1EA1-441A-93B6-FA310A4A4815Q36418765-394DC533-7859-4E81-AD04-412119FA9981Q36458809-E9EBC7B6-944F-4B7D-812E-28269FE3D630Q37348493-E2F3928D-E881-408E-8261-5CC1A811E645Q37434640-0F113418-A167-4415-9D76-B2A952411EE4Q37495629-A059B9AF-3620-4E99-A9AF-7763CEA39E38Q37495724-B0943C05-1A69-4DBB-97DC-FF7821788829Q37622130-55677EC9-2361-46D4-AF2B-E7FE965BB180Q37952821-B9C45387-F82A-46F8-8F44-6EB074CF2801Q37994844-65ABCD9A-AAA4-41ED-ADF9-2B8BC93BECABQ38037667-15A277F0-0C3F-447E-81C3-F09B82C2D963Q38041202-5806FBAF-D1F1-426D-93F4-19DAFCBCE519Q38051103-18E134F6-0A37-43A8-9498-161762FE9FC5Q38067776-3352A47A-BF16-413D-B648-80AD01B6CA4CQ38131689-AA057100-1D35-442E-892A-6C782A67A31AQ38258667-18F11F33-AF90-4D47-9475-B910610B68F2Q38790580-48EE3992-D039-4A8C-B9B3-45784D3383BBQ38938517-E680D5AF-9726-44AE-BFB6-B000E59327A5Q39037023-2861CDFD-C426-45F7-BACF-42E35FB24F43Q39119910-9377D7FC-91D4-4A75-9F90-C6E1A0601AFAQ39159567-68BF461B-0CC9-4ED4-92DF-BCCDC5DA8F9EQ39236932-50A486C2-6C8B-4DAE-B1DE-6D91089DE80B
P2860
Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Substrate and Trigger Ablation ...... ticentre, international trial.
@ast
Substrate and Trigger Ablation ...... ticentre, international trial.
@en
type
label
Substrate and Trigger Ablation ...... ticentre, international trial.
@ast
Substrate and Trigger Ablation ...... ticentre, international trial.
@en
prefLabel
Substrate and Trigger Ablation ...... ticentre, international trial.
@ast
Substrate and Trigger Ablation ...... ticentre, international trial.
@en
P2093
P2860
P356
P1476
Substrate and Trigger Ablation ...... ticentre, international trial.
@en
P2093
Atul Verma
Carlos A Morillo
Esteban G Torrecilla
Girish Nair
Guiseppe De Martino
Laurent Macle
Paul Novak
Peter G Guerra
Roberto Mantovan
P2860
P304
P356
10.1093/EURHEARTJ/EHQ041
P577
2010-03-09T00:00:00Z